Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 11,649 | 2,191 | 8,344 | 2,189 | 2,901 |
| Gross Profit | 11,649 | 2,191 | 8,344 | 2,189 | 2,901 |
| Operating Expenses | 18,400 | 18,463 | 17,295 | 13,803 | 13,612 |
| Operating Income | -6,751 | -16,272 | -8,951 | -11,614 | -10,711 |
| Interest Expense | 399 | 431 | 399 | 4 | 93 |
| Other Income | 2,152 | -11,301 | 166 | -22 | 98 |
| Pre-tax Income | -4,998 | -28,004 | -9,184 | -11,640 | -10,706 |
| Net Income Continuous | -4,998 | -28,004 | -9,184 | -11,640 | -10,706 |
| Minority Interests | N/A | N/A | N/A | 18,630 | -1,200 |
| Net Income | $-4,998 | $-28,004 | $-9,184 | $-30,270 | $-9,506 |
| EPS Basic Total Ops | -0.60 | -3.40 | -1.70 | -7.50 | -2.40 |
| EPS Basic Continuous Ops | -0.58 | -3.41 | -1.69 | -2.89 | -2.67 |
| EPS Diluted Total Ops | -0.60 | -3.40 | -1.70 | -7.50 | -2.40 |
| EPS Diluted Continuous Ops | -0.58 | -3.41 | -1.69 | -2.89 | -2.67 |
| EBITDA(a) | $-6,080 | $-15,613 | $-8,307 | $-10,947 | $-9,981 |